Chemical Compound
Moexipril related compound B
CAS Registry Number
103733-51-3
Primary Record
Moexipril related compound B
- In stock
- 3,342 g
- Purity
- 98.3 %
- CAS
- 103733-51-3
Compound Identifiers & Properties
- CAS
- 103733-51-3
- PubChem CID
- 71750760
- SMILES
- CCOC(=O)[C@H](CCC1=CC=CC=C1)N2[C@H](C(=O)N3CC4=CC(=C(C=C4C[C@H]3C2=O)OC)OC)C
- Canonical SMILES
- CCOC(=O)[C@H](CCc1ccccc1)N1C(=O)[C@@H]2Cc3cc(OC)c(OC)cc3CN2C(=O)[C@@H]1C
Names & Synonyms
- Moexipril related compound B
- Moexipril Diketopiperazine
- UNII-6SJ97G618S
- RefChem:202526
- 6SJ97G618S
- DIKETOPIPERAZINE MOEXIPRIL
- PD-114009
- Moexipril related compound B [USP]
- DTXSID40146037
- DTXCID5068528
- Moexipril related compound B RS [USP]
- UYPPDNXTLSUNRF-HSQYWUDLSA-N
- 103733-51-3
- Moexipril related compound B (USP)
- ZINC77311425
- Moexipril related compound B RS (USP)
- MOEXIPRIL RELATED COMPOUND B [USP-RS]
- PD 114009
- MOEXIPRIL RELATED COMPOUND B (USP-RS)
- MOEXIPRIL RELATED COMPOUND B [USP IMPURITY]
- (S)-Ethyl 2-((3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,4-dihydro-1H-pyrazino(1,2-b)isoquinolin-2(6H,11H,11ah)-yl)-4-phenylbutanoate
- MOEXIPRIL RELATED COMPOUND B (USP IMPURITY)
- Moexipril desethyl - H2O Me (Moexprilate - H2O Me)
- Q27265439
- 2H-Pyrazino(1,2-b)isoquinoline-2-acetic acid, 1,3,4,6,11,11a-hexahydro-8,9-dimethoxy-3-methyl-1,4-dioxo-alpha-(2-phenylethyl)-, ethyl ester, (alphaS,3S,11aS)-
- ethyl (2S)-2-[(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-3,6,11,11a-tetrahydropyrazino[1,2-b]isoquinolin-2-yl]-4-phenylbutanoate
- (|AS,3S,11aS)-1,3,4,6,11,11a-Hexahydro-8,9-dimethoxy-3-methyl-1,4-dioxo-|A-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetic Acid Ethyl Ester
- [3S-[2(R*),3|A,11a|A]]-1,3,4,6,11,11a-Hexahydro-8,9-dimethoxy-3-methyl-1,4-dioxo-|A-(2-phenylethyl)-2H-pyrazino[1,2-b]isoquinoline-2-acetic Acid Ethyl Ester
- 2H-PYRAZINO(1,2-B)ISOQUINOLINE-2-ACETIC ACID, 1,3,4,6,11,11A-HEXAHYDRO-8,9-DIMETHOXY-3-METHYL-1,4-DIOXO-.ALPHA.-(2-PHENYLETHYL)-, ETHYL ESTER, (.ALPHA.S,3S,11AS)-
- Ethyl (2S)-2-[(3S,11aS)-8,9-dimethoxy-3-methyl-1,4-dioxo-1,3,4,6,11,11a-hexahydro-2H-pyrazino[1,2-b]isoquinolin-2-yl]-4-phenylbutanoate